In PLoS One this week, investigators at McGill University report their use of exon-level transcriptome profiling in murine breast cancer, which revealed "splicing changes specific to tumors with different metastatic abilities." Specifically, in their statistical analysis the team found "significant expression changes in four percent of exons and one percent of intronic regions, affecting 2,263 out of 16,654 genes.